Levofloxacin Dosage and Administration for Pneumonia
Guideline-Based Recommendations for Community-Acquired Pneumonia
- The Infectious Diseases Society of America recommends levofloxacin 500 mg IV/PO once daily as monotherapy for patients with community-acquired pneumonia who do not have severe illness 1, 2
- The European Respiratory Society suggests that levofloxacin can be used as an alternative to beta-lactam plus macrolide combinations for community-acquired pneumonia 3, 1
Guideline-Based Recommendations for Hospital-Acquired Pneumonia
- The Infectious Diseases Society of America recommends levofloxacin 750 mg IV daily for hospital-acquired pneumonia, and it should be combined with an antipseudomonal beta-lactam if P. aeruginosa is suspected 2
- The American Thoracic Society states that levofloxacin 750 mg IV daily is appropriate as monotherapy only when MRSA prevalence is <20% and patient is not high-risk for mortality 2
Critical Dosing Considerations
- The Infectious Diseases Society of America recommends using the higher 750 mg dose of levofloxacin for severe community-acquired pneumonia or hospital-acquired pneumonia 2
- The European Respiratory Society suggests that the standard 500 mg dose of levofloxacin is appropriate for mild to moderate community-acquired pneumonia in hospitalized ward patients 1
Important Clinical Caveats
- The Infectious Diseases Society of America advises against using levofloxacin if the patient received fluoroquinolones within the past 90 days due to high risk of resistant organisms 5
- The American Thoracic Society states that levofloxacin does not adequately cover MRSA, and vancomycin or linezolid should be added if MRSA risk factors are present 2
IV to Oral Transition
- The Infectious Diseases Society of America recommends switching to oral levofloxacin when the patient is clinically stable, afebrile for 24 hours, and able to take oral medications 1, 4